Oliveira, Ivan Pires de 
; Lescano, Caroline Honaiser ; De Nucci, Gilberto
Fonte: Scientia Pharmaceutica. Unidade: ICB
Assuntos: FARMACOLOGIA, INIBIDORES DE ENZIMAS, ENZIMAS HIDROLÍTICAS, HIDRÓLISE, CATÁLISE, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Ivan Pires de e LESCANO, Caroline Honaiser e DE NUCCI, Gilberto. In silico mapping of essential residues in the catalytic domain of PDE5 responsible for stabilization of its commercial inhibitors. Scientia Pharmaceutica, v. 87, n. 4, p. 14 , 2019Tradução . . Disponível em: https://doi.org/10.3390/scipharm87040029. Acesso em: 30 set. 2024.APA
Oliveira, I. P. de, Lescano, C. H., & De Nucci, G. (2019). In silico mapping of essential residues in the catalytic domain of PDE5 responsible for stabilization of its commercial inhibitors. Scientia Pharmaceutica, 87( 4), 14 . doi:10.3390/scipharm87040029NLM
Oliveira IP de, Lescano CH, De Nucci G. In silico mapping of essential residues in the catalytic domain of PDE5 responsible for stabilization of its commercial inhibitors [Internet]. Scientia Pharmaceutica. 2019 ; 87( 4): 14 .[citado 2024 set. 30 ] Available from: https://doi.org/10.3390/scipharm87040029Vancouver
Oliveira IP de, Lescano CH, De Nucci G. In silico mapping of essential residues in the catalytic domain of PDE5 responsible for stabilization of its commercial inhibitors [Internet]. Scientia Pharmaceutica. 2019 ; 87( 4): 14 .[citado 2024 set. 30 ] Available from: https://doi.org/10.3390/scipharm87040029
